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Abstract Here we summarize evidence obtained by our
group during the last two decades, and contrasted it with a
review of related data from the available literature to show
that behavioral syndromes involving attention deﬁcit/
hyperactivity disorder (ADHD), externalizing disorders,
and substance-use disorder (SUD) share similar signs
and symptoms (i.e., have a biological basis as common
syndromes), physiopathological and psychopathological
mechanisms, and genetic factors. Furthermore, we will
show that the same genetic variants harbored in different
genes are associated with different syndromes and that
non-linear interactions between genetic variants (epistasis)
best explain phenotype severity, long-term outcome, and
response to treatment. These data have been depicted in our
studies by extended pedigrees, where ADHD, externalizing
symptoms, and SUD segregate and co-segregate. Finally,
we applied here a new formal network analysis using the
set of signiﬁcantly replicated genes that have been shown
to be either associated and/or linked to ADHD, disruptive
behaviors, and SUD in order to detect signiﬁcantly enri-
ched gene categories for protein and genetic interactions,
pathways, co-expression, co-localization, and protein
domain similarity. We found that networks related to
pathways involved in axon guidance, regulation of synaptic
transmission, and regulation of transmission of nerve
impulse are overrepresented. In summary, we provide
compiled evidence of complex networks of genotypes
underlying a wide phenotype that involves SUD and
externalizing disorders.
Introduction
Complex phenotypes or traits result from a complicated
interplay involving pleiotropy (production by a single gene
of two or more effects), genetic heterogeneity (production
of the same effect by two or more genes), epistasis (non-
lineal genetic interactions), and environmental forces
(Acosta et al. 2004). This type of trait exhibits a prefer-
ential familial clustering that cannot be explained by
environmental causes alone, including shared cultural
inﬂuences, and typically does not display patterns of
Mendelian segregation (Acosta et al. 2004).
One of the best examples that demonstrate the way in
which interacting effects can give rise to complex pheno-
types is autoimmune disease (AID). Any chronic condition
initiated by loss of immunological tolerance to self-anti-
gens is considered an AID (Anaya 2010), part of a heter-
ogeneous group of disorders that afﬂict speciﬁc target
organs or multiple organ systems. Even though speciﬁc
epidemiological, clinical, and pathological features deﬁne
different AIDs, they have a number of clinical signs and
symptoms in common. They also share pathophysiological
mechanisms and genetic factors. Furthermore, it is possible
to ﬁnd in a single patient more than one AID. More
interestingly, one pedigree might include a cluster of many
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(Anaya 2010). Mutations in one gene might be associated
with several AIDs (Jin et al. 2010; Spritz 2011) and vari-
ants in two genes might converge in a cooperative inter-
action (epistasis) to outline a complex AID phenotype, as
described in membranous nephropathy (Stanescu et al.
2011). Autoimmune diseases preferentially tend to affect
females (i.e., they demonstrate a gender bias), share similar
causal environmental agents, and several AIDs might
respond to the same pharmacological treatment (Anaya
2010).
Evidence derived from several studies by our group
suggests that common mental disorders of childhood and
adolescence form a similar picture to that of the AIDs.
The Diagnostic and Statistical Manual of Mental Disorders
(DSM-IV) includes in its classiﬁcation attention deﬁcit/
hyperactivity disorder (ADHD), disruptive behavior dis-
orders including conduct disorder (CD) and oppositional
deﬁant disorder (ODD), as well as substance-use disorder
(SUD). In the following sections, we will present data that
support our model proposing that these constructs, grouped
under the label ‘‘externalizing disorders’’, can be consid-
ered to be related syndromes, and that they share common
physiopathological and psychopathological mechanisms,
with evidence for common underlying genetic factors
(Fig. 1) (Acosta et al. 2004; Arcos-Burgos et al. 2004a,
2010; Elia et al. 2009; Jain et al. 2011; Martinez et al.
2011; Pineda et al. 2011; Ribases et al. 2011).
Furthermore, we show that same genetic variants, har-
bored at different genes (loci), may be associated with
different syndromes (Arcos-Burgos and Muenke 2010; Jain
et al. 2007) and, in particular cases, non-linear interactions
between these variants (epistasis) correlate with the spe-
ciﬁc phenotype, the severity of that phenotype, the long-
term clinical outcome, and response to treatment (Jain et al.
2011). In addition, we will demonstrate that in extended
pedigrees, ADHD, externalizing symptoms, and SUD can
all be present simultaneously in one individual, and also,
that different members of a single pedigree can exhibit
variable combinations of these syndromes (Fig. 2). Finally,
by applying formal network analysis, we will show that
these apparently unrelated genes are overrepresented by
statistically signiﬁcant gene ontology (GO) networks rela-
ted to pathways such as those that involve axon guidance,
regulation of synaptic transmission, and regulation of
transmission of nerve impulse.
Deﬁnitions and background
Attention deﬁcit/hyperactivity disorder is the most com-
mon neurodevelopmental behavioral disorder of childhood
Fig. 1 Physiopathological and psychopathological mechanisms, and
genetic factors shared by attention deﬁcit hyperactivity disorder
(ADHD), conduct disorder (CD), oppositional deﬁant disorder (ODD)
and substance-use disorder (SUD)
Fig. 2 An extended pedigree
demonstrating ADHD,
externalizing symptoms, and
associated conditions including
nicotine, dependence and
alcohol abuse and/or
dependence. With modiﬁcations
from Palacio et al. (2004)
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elevated levels of inattention and/or hyperactive or
impulsive behaviors that cause signiﬁcant impairment
(American Psychiatric Association 2000). Attention deﬁcit/
hyperactivity disorder affects 10 % of children and ado-
lescents in the US (Visser et al. 2010); affected individuals
are at increased risk for poor educational achievement, low
income, underemployment, legal difﬁculties, and impaired
social relationships (Arcos-Burgos et al. 2010). A conser-
vative estimate of the annual societal cost of ADHD in
childhood and adolescence is $ 42.5 billion in the US alone
(Pelham et al. 2007).
Other externalizing disorders of childhood besides
ADHD include CD, ODD, and juvenile bipolar disorder.
Although ADHD can occur as a single disorder in a
minority of diagnosed individuals, it generally co-occurs
with other disruptive behaviors disorders and with SUD
(Palacio et al. 2004).
Substance-use disorder, a term that includes substance
abuse and dependence, is characterized by compulsive drug
seeking and drug use even in the face of severe adverse
consequences. The World Health Organization estimates
that there are at least 2 billion alcohol users, more than
1 billion tobacco users, and almost 185 million illicit drug
users worldwide (Li and Burmeister 2009). Vulnerability to
addictions is a complex trait with strong genetic inﬂuences
that are largely shared by abusers of different legal and
illegal addictive substances (Karkowski et al. 2000; Liu
et al. 2006; True et al. 1999; Tsuang et al. 1998; Uhl et al.
2001).
ADHD plus SUD: Individuals with ADHD are at
increased risk for SUD (Bukstein 2008; Molina BSGM
1999; Szobot et al. 2007). Children diagnosed with ADHD
monitored during the transition into adolescence exhibited
higher rates of alcohol, tobacco, and psychoactive drug use
than control groups of children without ADHD (Biederman
et al. 1995; Molina and Pelham 2003). The lifetime risk for
SUD is approximately 50 % in subjects with childhood
ADHD that persists into adulthood (Biederman et al. 1995).
Similarly, a high ADHD prevalence is found in adolescents
with SUD (DeMilio 1989; Horner and Scheibe 1997;
Kuperman et al. 2001). Also, it affects SUD prognosis:
ADHD is associated with both earlier and more frequent
alcohol-related relapses (Ercan et al. 2003)a n dl o w e rl i k e -
lihood of cannabis treatment completion (White et al. 2004).
Regardless of the type of substance, longitudinal studies
demonstrate that ADHD onset precedes SUD, suggesting
that the psychopathology of ADHD is not typically sec-
ondary to SUD (Wilens and Biederman 2006). As ADHD
precedes SUD, it is reasonable to hypothesize that timely
diagnosis and treatment of ADHD may reduce the occur-
rence and/or severity of SUD. Indeed, in a recent meta-
analysis of six studies in which children with ADHD were
treated with stimulants, the most common pharmacother-
apy, SUD was less common in adolescence in treated
versus non-pharmacologically treated children (Wilens
et al. 2003).
Though the basis of the connection remains unclear,
several theories have been proposed to explain the
increased risk for SUD in patients with ADHD. Genetically
mediated personality traits, such as novelty seeking and
impulsivity, are common to ADHD and SUD, and they
may provide a link to common neurologic substrates
(Chambers et al. 2003; Wilens and Biederman 2006). It has
also been proposed that patients with ADHD use addictive
substances in an attempt to self-medicate symptoms of the
disorder (Khantzian 1997), and that the poor judgment and
impulsivity associated with ADHD contribute to the
development of dependence (Wilens and Biederman 2006).
A proposed genetic network underlying ADHD, CD,
ODD, and SUD
Clustering of ADHD, CD, ODD, and SUD in pedigrees
In 18 extended multigenerational families recruited from
the genetically isolated Paisa community in Colombia, we
found that a high proportion of individuals were affected
with ADHD (32.8 %). These families also had high rates of
CD (50 %; OR = 11.5, 95 % CI = 6.4–20.9), ODD
(25.4 %; OR = 2.7, 95 % CI = 1.5–4.8), and associated
conditions, including nicotine, dependence and alcohol
abuse and/or dependence (Fig. 2) (Palacio et al. 2004),
which were often comorbid with ADHD.
Linkage studies of ADHD
We applied model-based and model-free linkage analyses
and the pedigree disequilibrium test (PDT)(Martin et al.
2000) to genome-wide scan genotype data obtained for the
Paisa families and found evidence of linkage to markers at
chromosomes 4q13.2, 5q33.3, 8q11.23, 11q22, and 17p11
in individual families (Arcos-Burgos et al. 2004b). Fine
mapping of these regions in the combined families resulted
in signiﬁcant linkage at chromosomes 4q13.2 (two-point
allele sharing LOD score from LODPAL = 4.44 at
D4S3248), 5q33.3 (two-point allele sharing LOD score
from LODPAL = 8.22 at D5S490), 11q22 (two-point
allele sharing LOD score from LODPAL = 5.77 at
D11S1998, multipoint NPL -log(P) = 5.49 at *128 cM)
and 17p11 (multipoint NPL -log(P) [12 at *12 cM,
multipoint MLS = 2.48 (a = 0.10) at *12 cM, two-point
allele sharing LOD score from LODPAL = 3.73 at
D17S1159). In addition, suggestive linkage at chromosome
8q11.23 was found (combined two-point NPL -log(P)[3.0
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123at D8S2332) (Arcos-Burgos et al. 2004b). Several of these
regions were novel (4q13.2, 5q33.3, and 8q11.23) while
others strongly replicated published loci (11q22 and
17p11). In summary, we identiﬁed linkage to the same
genomic regions in different pedigrees, and to several
genomic regions in speciﬁc pedigrees. These ﬁndings are
compatible with the effects of epistasis and pleiotropy,
respectively. The strong concordance between different
analytical methods of linkage and the replication of data
between two independent studies suggest that these loci
harbor ADHD susceptibility genes (Fig. 3) (Arcos-Burgos
et al. 2004b).
Linkage and association commonalities of ADHD, CD,
ODD, and SUD
Both linkage- and association-based genome scans have
been conducted for speciﬁc drug dependencies as well as
the vulnerability to addiction. While each study has iden-
tiﬁed many different loci, these data converge to likely
represent true contributions of common allelic variants to
polygenic models of genetic vulnerability to polysubstance
abuse, and to some psychiatric conditions that share com-
mon manifestations (Fig. 4).
In the extended and multigenerational Paisa pedigrees
segregating ADHD comorbidly with ODD, CD, alcohol
abuse/dependence, and nicotine dependence, we found
that ADHD co-segregates with disruptive behaviors as a
phenotypically variable trait, as evidenced by highly
signiﬁcant pair-wise linkages among ADHD and ODD
(LOD = 14.19), ADHD and CD (LOD = 5.34), ODD and
CD (LOD = 6.68), and CD and alcohol abuse/dependence
(LOD = 3.98). In addition, we found evidence of linkage
for comorbid ADHD phenotypes to loci at 8q24,
2p21–22.3, 5p13.1–p13.3, 12p11.23–13.3, 8q15, 11q22,
and 14q21.1–22.2, suggesting that these patterns of co-
segregation of ADHD with disruptive behavior and sub-
stance abuse comorbidities, and the linkage to similar
regions, were indicative of a common major genetic cause
(Jain et al. 2007). As additional evidence, some of these
regions were highlighted by other studies, particularly the
11q22 chromosomal region that harbors the NCAM1,
TTC12, ANKK1, and DRD2 genes (Table 1).
Evidence of linkage and association of ADHD, CD,
ODD, and SUD to LPHN3
Using the integration of statistical and functional approa-
ches, we discovered a novel gene that segregates with
ADHD and contributes to disease susceptibility; this gene
is harbored in the chromosome 4q region previously found
to be linked to ADHD (Fig. 5). The application of ﬁne
mapping to these linked families sharpened the linkage
signal and revealed new meiotic recombination events in
individuals with ADHD, which further narrowed the min-
imal critical region with the gene to *20 Mb (Arcos-
Burgos et al. 2010) (Fig. 5). Fine-scale genetic association
was conducted in nuclear and large multigenerational Paisa
families. Areas of interest included those that were gene-
rich or that included potential candidate genes, and were
covered at a higher density (Arcos-Burgos et al. 2010).
Using family-based association strategies and haplotype-
based cladistic analysis, a signiﬁcant area of association
with ADHD was then deﬁned by the single nucleotide
polymorphic (SNP) markers rs1901223 and rs1355368
(P = 3.1 9 10
-3, marker-based; P = 2.7 9 10
-5, haplo-
type based) (Arcos-Burgos et al. 2010) (Fig. 5).
The region of association was located at 62.4–62.7 Mb
(UCSC coordinates) on 4q within exons 4 through 19 of the
Latrophilin3 gene (LPHN3) (Arcos-Burgos et al. 2010).
Latrophilin3 is a member of the latrophilin (LPHN) sub-
family of G-protein coupled receptors (GPCRs). Genes
encoding the GPCRs, such as DRD4 and DRD5, have also
been shown to be associated with ADHD (Arcos-Burgos
et al. 2010) (Fig. 6a).
Latrophilins have seven transmembrane regions, a long
N-terminal extracellular sequences containing a 19-amino
acid signal peptide (GPCR proteolytic site, GPS domain),
and a serine/threonine-rich glycosylation region (Martinez
et al. 2011). Latrophilins 1 and 2 serve as receptors for
a-latrotoxin, a component of the venom of the black widow
spider (Martinez et al. 2011); this component interacts
with neuronal GPCRs to stimulate exocytosis of GABA-
containing presynaptic vesicles. GABA is an inhibitory
neurotransmitter. As LPHN3 is the most brain-speciﬁc
latrophilin, it suggests a possible role in ADHD (Martinez
et al. 2011) (Fig. 6b).
Once the study of Paisa families identiﬁed a speciﬁc
region of the LPHN3 gene associated with ADHD, ﬁne
mapping was performed. This allowed us to precisely
pinpoint variants in the DNA code that may alter function.
In order to validate these ﬁndings, we pursued replication
in additional samples from Colombia, Germany, Norway,
Spain, and in two separate US populations. These meta-
analyses showed evidence for a signiﬁcant homogeneous
genetic effect for three of the top associated markers inside
the LPHN3 gene (Arcos-Burgos et al. 2010). Replication of
the association of LPHN3 with ADHD in adults was also
found in an independent sample from Spain (Ribases et al.
2010).
Combined efforts of this collaboration revealed poten-
tially functional sequences within the LPHN3 gene that
may be considered targets for future studies. These ﬁndings
are thus not only a step toward a better understanding of
920 Hum Genet (2012) 131:917–929
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groups can interact to dissect causes of genetically complex
human diseases (Arcos-Burgos et al. 2010).
In addition to the genetic studies, we carried out path-
ologic studies of brain specimens and neuroimaging
studies. This showed that a key LPHN3 variant of interest
is expressed in brain regions related to attention and
activity including the amygdala, caudate nucleus, cerebel-
lum, and cerebral cortex. Importantly, the same variant
associated with ADHD was also associated with response
Fig. 3 Model-based and model-free linkage analyses in extended and
multigenerational Paisa families found evidence of linkage to markers
at chromosomes 4q13.2, 5q33.3, 8q11.23, 11q22, and 17p11. These
results were compatible with the presence of epistasis and pleiotropy
in replication studies, suggesting that these loci harbor ADHD
susceptibility genes. With modiﬁcations from Arcos-Burgos et al.
(2004b)
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other words, speciﬁc DNA sequence changes in the gene
coding for LPHN3 were associated with and predicted
whether or not a person with ADHD responded to and
beneﬁtted from treatment with stimulant medication.
LPHN3 is thus an example of a locus where multiple
independent psychiatric studies converge, and recapitulates
earlier ﬁndings involving SUD. Initially, alcohol abuse was
linked to Chromosome 4 in the area of LPHN3 (Long et al.
1998). This study investigated a Southwestern American
Fig. 4 Linkage- and association-based genome scans identiﬁed loci containing common allelic variants contributing to SUD and to some
psychiatric conditions
Table 1 Results from GWAS and candidate gene approaches showing replicated genes associated with ADHD and SUD
Trait Chr. Marker P value Gene region Type of study Reference
ADHD 2 rs2556378 8.4 9 10
-7 BCL11A GWAS case–control Hinney et al.
(2011)
ADHD 11 rs5016282 1.8 9 10
-6 GRM5 GWAS case–control Hinney et al.
(2011)
ADHD 16 rs8045006 2.3 9 10
-5 CDH13 GWAS case–control Neale et al.
(2010)
Smoking
behavior
11 rs10502172 9.1 9 10
-6 TTC12-ANKK1-
DRD2
Candidate gene case–control association Ducci et al.
(2011)
Smoking
behavior
15 rs1051730, 1.1 9 10
-5 CHRNA3 Candidate gene case–control association Ducci et al.
(2011)
Tobacco
smoking
11 rs2303380–rs4938015–
rs11604671
4.3 9 10
-2 TTC12-ANKK1-
DRD2
Candidate gene case–control
association, black and white
populations
David et al.
(2010)
Alcohol
dependence
11 rs1893699–rs723077 2.1 9 10
-4 NCAM1, TTC12,
ANKK1, DRD2
Candidate gene case–control and
family-based association
Yang et al.
(2007,
2008)
Nicotine
dependence
11 rs2303380–rs4938012–
rs4938015–rs11604671
1.0 9 10
-8 NCAM1-TTC12-
ANKK1-DRD2
Candidate gene case–control association Gelernter
et al. (2006)
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linkage to marker D4S1645, which is less than 300 kb
upstream of LPHN3. Another independent study utilized
two-point linkage analysis in families with alcohol
dependence to identify a nominally signiﬁcant locus at
D4S244 (Reich et al. 1998), which is *5 Mb downstream
of LPHN3. While its distance from LPHN3 makes this
latter report less compelling, it nonetheless suggests that
there is a locus on chromosome 4p related to alcohol
dependence (Uhl 2004a, b).
Additional evidence is supplied by a third study that
utilized whole genome association analysis to identify
SNPs with signiﬁcant allele frequency differences between
abusers of illegal substances and control populations of
both European-American (EA) and African-American
(AA) ethnicities (Liu et al. 2006). This study identiﬁed
three SNPs within LPHN3 that are positive for association
(Monte Carlo P = 5.89 9 10
-3). This group utilized this
information and replicated these as well as additional
LPHN3 SNPs in several populations including polysub-
stance abuser individuals from the National Institute on
Drug Abuse (NIDA) (Bergen et al. 1999), samples from
alcohol-dependent individuals from the Collaborative
Studies on Genetics of Alcoholism (COGA) (Johnson et al.
2006; Liu et al. 2006), and samples from methampheta-
mine-dependent individuals from Japan and Taiwan (Uhl
et al. 2008a, b).
We also provided evidence of epistasis underlying
ADHD by screening for potential interactions between
ADHD-linked loci, where we found a signiﬁcant correlation
between 4q and 11q (P\1 9 10
-8) (Jain et al. 2011).
Conditioning on the LPHN3 associated SNP, rs6551665,
and using case–control and family-based designs, we
detected interacting effects with a haplotype harbored on
11q (P\5 9 10
-6). This haplotype encompasses Neural
Cell Adhesion Molecule 1 (NCAM1), a gene with a funda-
mental role in neural development, the Dopamine Receptor
D2 (DRD2), a gene previously associated with ADHD, and
the Tetratricopeptide Repeat Domain 12 (TTC12), and
Ankyrin repeat and Kinase Domain Containing 1 (ANKK1),
two genes associated with externalizing symptoms and
nicotine dependence (David et al. 2010; Ducci et al. 2011;
Gelernter et al. 2006; Yang et al. 2007, 2008) (Table 1).
Using three additional ADHD datasets that previously
showed the association of ADHD with LPHN3, the
LPHN3-11q interaction was replicated by formal meta-
analysis (Jain et al. 2011). The effect of the interaction
represents a two-fold increase from the original risk
conferred by LPHN3 to develop ADHD (OR = 2.46,
95 % CI = 1.63–3.70, P = 5.09 9 10
-6). In addition, the
LPHN3-11q interaction more signiﬁcantly demonstrates
the effect that the LPHN3 susceptibility variant has on both
ADHD response to stimulant medication and on brain
metabolism (Jain et al. 2011). Furthermore, we demon-
strated that this genetic interaction not only predicts ADHD
severity but also long-term outcome, which is related to
comorbidities (Acosta et al. 2011).
Evidence of linkage and association of the
NCAM1-TTC12-ANKK1-DRD2 gene cluster to SUD
A prospective study of 4,762 ﬁnish subjects (52 % female)
for whom smoking behaviors were ascertained at age 14
and 31 years, evaluated the developmental changes and the
potential effect of genetic and non-genetic factors (Ducci
et al. 2011). In this study, the A allele of rs1051730 SNP
marker, located in the Cholinergic Receptor alpha 3
(CHRNA3) gene, was found to have a similar effect-size at
14 years and 31 years and was more common in those
described as heavy/regular smokers compared to those who
did not smoke (P = 1.1 9 10
-5).
Markers in the TTC12-ANKK1-DRD2 genomic region
have been also associated with smoking behavior, with
rs10502172 (P = 9.1 9 10
-6) being the most signiﬁcantly
associated marker. This marker is located within the TTC12
gene; individuals with the G variant had 1.33 (95 % CI =
1.11–1.60) times higher risk of being smokers at age 14,
and 1.14 (95 % CI = 1.02–1.28) times higher risk of being
smokers at age 31 years. In adolescence, this variant also
conferred increased risk of occasionally (OR = 1.12, 95 %
Fig. 5 ADHD mapping by LD using cladistic analyses with closely
spaced SNP markers across the critical region in 137 additional
nuclear families reveals an area of association between 62.4 and
62.7 Mb in chromosome 4 (in red). With modiﬁcations from Arcos-
Burgos et al. (2010)
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more, variants in the ANKK1 (rs2734849) and DRD2
(rs1076563) genes were also found to be signiﬁcantly
associated with smoking behavior.
In tobacco smoking, linkage studies and haplotype-
based analyses on the TTC12-ANKK1-DRD2 gene cluster
have also elucidated genetic and sex-speciﬁc associations
with smoking behavior (David et al. 2010). Seven SNPs
within this gene cluster were tested using longitudinal data
from 1993 to 1994 and 2004 to 2005 in 638 individuals
(including 270 individuals of black and 368 of white eth-
nicity) from the Baltimore Epidemiologic Catchment Area
(ECA) cohort study. Evidence was provided for sex-
speciﬁc differences in smoking behavior. First, black male
smokers with the GTG haplotype (deﬁned by the markers
rs2303380–rs4938015–rs11604671) were more likely to
stop smoking 11 years later (55.6 % GTG vs. 22.0 % other
haplotypes), in contrast with black women who had other
haplotypes (20.8 % GTG vs. 24.0 % other haplotypes).
Conversely, the same haplotype (vs. other haplotypes) was
signiﬁcantly associated with a lifetime history of daily
smoking (OR = 1.6, 95 % CI = 1.1–2.4) and a higher
prevalence of smoking initiation (77.6 % GTG vs. 57.0 %
other haplotypes) in white individuals. Second, a different
haplotype block was identiﬁed when comparing black
and white individuals; this block consisted of one SNP
within TTC12 (rs2303380) and three in ANKK1 (markers
rs4938012, rs4938015, and rs11604671).
Fig. 6 a The susceptibility haplotype encompasses exons 4–19 of
LPHN3, and contains important functional domains and variable
splicing sites for isoforms of the gene. There are not other genes
annotated over the region spanned by the susceptibility haplotype.
b General structure of latrophilins. The long extracellular region
contains four domains: a SUEL LECTIN domain, a region homol-
ogous to olfactomedins and myocilin, a homology region (HR) with
BAI1-3, and a cysteine-rich GPCR proteolysis site (gps). With
modiﬁcations from Arcos-Burgos et al. (2010)
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haplotype analyses with 43 SNPs within the NCAM1-
TTC12-ANKK1-DRD2 gene cluster have been performed
in studies of alcohol dependence (AD) (Yang et al. 2007)
and drug dependence (DD) (Yang et al. 2008). In the ﬁrst
study, two separate association studies of AD were con-
ducted on 1,220 individuals of EA ancestry using family-
based (488 individuals) and case–control (732 individuals,
43.4 % cases) designs (Yang et al. 2007). In this study,
haplotypic variants within this gene cluster were associ-
ated with AD at TTC12 (markers rs1893699–rs723077) in
both the case–control and family-based samples, as well as
variants around exon 12 of NCAM1 and exons 2 and 5 of
ANKK1 only in the case–control sample. For DD, two
separate association studies of AD with DD (AD ? DD)
and AD without DD (AD-only) in 1,090 individuals of
EAs were performed using the aforementioned designs
and the same genetic variants (Yang et al. 2008). More
evidence was provided for the association of haplotypic
variants in exon 3 of TTC12, exon 12 of NCAM1, and the
two 30-ends of ANKK1 and DRD2 as co-effectors of AD
and DD.
It is intriguing that variants within the NCAM1-TTC12-
ANKK1-DRD2 gene cluster were also found to be strongly
associated with nicotine dependence (ND) in two inde-
pendent American populations, consisting of 1,615 indi-
viduals from AA and EA ancestry (Gelernter et al. 2006).
These individuals were based on affected sibling pairs with
cocaine or opioid dependence. Forty-three SNPs were
genotyped (see above). Of these, four markers (rs4938012,
rs4938013, rs4938015, and rs11604671) located in the
ANKK1 gene were signiﬁcantly associated with ND in EA,
and only the ﬁrst two markers reached nominal signiﬁcance
in AA. In TTC12, the most statistically signiﬁcant marker
was rs2303380 (P\0.0007 in AAs; P\0.007 in EAs).
Haplotype analyses performed on the most signiﬁcantly
associated markers (rs2303380, rs4938012, rs4938015, and
rs11604671) demonstrated a signiﬁcant association of this
SNP combination with ND in the individual (P\0.0003
for AAs; P\0.0008 for EAs) and pooled (P\0.000005)
samples. Furthermore, the GATC haplotype was associated
with ND (EAs: P\0.00006; AAs: P\0.0008; pooled:
P\0.0000001) showing strong evidence for association of
the same haplotype with ND. In these two distinct popu-
lations, the AGCT and AGTC haplotypes were associated
with decreased risk of ND (EAs: P\0.001; AAs:
P\0.0009) (Gelernter et al. 2006).
Evidence of a genetic network underlying ADHD, CD,
ODD, and SUD
In order to contrast the main hypothesis of the manuscript,
i.e., the existence of a network of genes underlying these
complex phenotypes, we performed a formal network
analysis with the LPHN3, NCAM1, TTC12, ANKK1,
DRD2, and CDH13 genes, a set of signiﬁcantly replicated
genes either associated and/or linked to ADHD, disruptive
behaviors, and SUD (Table 1). In addition, in order to
detect signiﬁcantly enriched gene categories within this set
of genes, we performed analyses with the GeneMANIA
Pathway Analysis software (http://genemania.org/). Gene-
MANIA uses a large set of available functional association
Table 2 Genes overrepresented in gene ontology (GO) networks
involving the LPHN3, NCAM1, TTC12, ANKK1, DRD2, and CDH13
genes
Gene Name
SLC6A3 Solute carrier family 6 (neurotransmitter transporter,
dopamine), member 3
ST8SIA3 ST8 alpha-N-acetyl-neuraminide alpha-2,8-
sialyltransferase 3
ST8SIA2 ST8 alpha-N-acetyl-neuraminide alpha-2,8-
sialyltransferase 2
ST8SIA4 ST8 alpha-N-acetyl-neuraminide alpha-2,8-
sialyltransferase 4
PPP1R9B Protein phosphatase 1, regulatory (inhibitor) subunit 9B
ADIPOQ Adiponectin, C1Q and collagen domain containing
GFRA1 GDNF family receptor alpha 1
FGFR1 Fibroblast growth factor receptor 1
ADORA2A Adenosine A2a receptor
GDNF Glial cell derived neurotrophic factor
PRNP Prion protein
NCS1 Neuronal calcium sensor 1
AGA Aspartylglucosaminidase
CLIC6 Chloride intracellular channel 6
AGRN Agrin
GIPC1 GIPC PDZ domain containing family, member 1
MDK Midkine (neurite growth-promoting factor 2)
HOXB8 Homeobox B8
NCAN Neurocan
KCNJ3 Potassium inwardly-rectifying channel, subfamily J,
member 3
ZNF24 Zinc ﬁnger protein 24
FGFR2 Fibroblast growth factor receptor 2
KCNJ5 Potassium inwardly-rectifying channel, subfamily J,
member 5
CADPS Ca
??-dependent secretion activator
KCNJ6 Potassium inwardly-rectifying channel, subfamily J,
member 6
MPDZ Multiple PDZ domain protein
CADPS2 Ca
??-dependent secretion activator 2
GNAZ Guanine nucleotide binding protein (G protein),
alpha z polypeptide
PCDH17 Protocadherin 17
HOXA5 Homeobox A5
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expression, co-localization, and protein domain similarity.
We found additional genes in pathways (Table 2 and
Fig. 7), as well as functions that frame these apparently
unrelated genes to statistically signiﬁcant gene ontology
(GO) networks related to pathways, such as axon guidance,
regulation of synaptic transmission, and regulation of
transmission of nerve impulse, among others (Table 3).
These results are compatible with other network analy-
ses that used the most highly ADHD-associated genes,
which found that they encode proteins involved in directed
neurite outgrowth (Poelmans et al. 2011). With this addi-
tional data, we show that common genetic variants har-
bored in the LPHN3, NCAM1, TTC12, ANKK1, DRD2, and
CDH13 genes, known to predispose to ADHD and to dis-
ruptive behavior symptoms present in ODD, CD, and SUD,
are overrepresented in a network of genes ontologically
linked to neurodevelopment. Future deep sequencing of the
genomic regions harboring these variants will allow us to
deﬁne true functional causal mutations. Identiﬁed common
and rare genetic variants, together with clinical covariate
information, plus data of brain function provided by fMRI,
will in the future provide a predictive framework suitable
to be used in clinical assessment and prevention of these
common behavioral disorders.
Physical interactions 
Co-expression 
Predicted 
Pathway 
Co-localization 
Shared protein domains 
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Fig. 7 Results from a formal network analysis using the ANKK1,
TTC12, DRD2, NCAM1, LPHN3, and CDH13 genes in order to detect
signiﬁcantly enriched gene categories for protein and genetic
interactions, pathways, co-expression, co-localization and protein
domain similarity. These selected genes were signiﬁcantly replicated
as being either associated and/or linked to ADHD, disruptive
behaviors and SUD. Networks related to pathways involved in
processes such as axon guidance, regulation of synaptic transmission
and regulation of transmission of nerve impulse were overrepre-
sented. For more information see Tables 2 and 3
Table 3 Gene ontology (GO) networks overrepresented when con-
sidering the LPHN3, NCAM1, TTC12, ANKK1, DRD2, and CDH13
genes
GO ID Description q value
0007411 Axon guidance 1.90 9 10
-5
0050804 Regulation of synaptic transmission 3.97 9 10
-3
0005242 Inward rectiﬁer potassium channel activity 4.32 9 10
-3
0051969 Regulation of transmission of nerve
impulse
4.32 9 10
-3
0031644 Regulation of neurological system process 4.32 9 10
-3
0008373 Sialyltransferase activity 4.68 9 10
-3
0051937 Catecholamine transport 5.01 9 10
-3
0015844 Monoamine transport 1.18 9 10
-2
0015850 Organic alcohol transport 2.79 9 10
-2
0034705 Potassium channel complex 3.59 9 10
-2
0008076 Voltage-gated potassium channel complex 3.59 9 10
-2
0005249 Voltage-gated potassium channel activity 3.59 9 10
-2
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